Skip to main content
. 2019 Jun 1;9(6):1266–1281.

Figure 8.

Figure 8

DSF/Cu and proteasome inhibitor bortezomib induce autophagy and apoptosis of cancer cells. The UACC-812 (A) and PDAC6 (B) cell lines were treated with either DSF/Cu, bortezomib, or NF-κBi, at indicated doses for 24 hours. Treated cells were lysed and analyzed by Western blot for levels of LC3II/I and cleaved PARP.